Advances in Radiotherapy for Head and Neck Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 25 October 2024 | Viewed by 14340
Special Issue Editor
Special Issue Information
Dear Colleagues,
Radio(chemo)therapy is a standard of care, both in primary and adjuvant settings, in the treatment of head and neck cancer. Efficacy improvements mainly originate from the introduction of technical advances, altered fractionation regimens, new concomitant administration of targeted drugs, and integration of molecular imaging in target volume delineation.
The aim of this Special Issue is to present a series of original (pre)clinical trials/translational studies/review articles that will highlight the progress that has been made in the management of head and neck cancer.
The topics of interest include, but are not limited to, the following: chemoradiotherapy; radioimmunotherapy; hypoxia and radiotherapy; sterotactic radiotherapy; patient-reported outcome and radiotherapy; de-escalation strategies; proton therapy; flash therapy; follow-up strategies; biomarker and patient stratification.
Dr. Francesca De Felice
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- head and neck cancer
- radiotherapy
- radiochemotherapy
- proton
- carbon ion
- machine learning
- clinical outcomes
- HPV
- immunotherapy
- targeted agents
- PET/TC
- RM
- re-irradiation